Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PTC THERAPEUTICS, INC. Director's Dealing 2020

Jan 9, 2020

31046_dirs_2020-01-08_332508cf-7db1-4647-84f1-d19dedd2b608.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2019-12-30

Reporting Person: Souza Marcio (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-12-30 Common Stock G 1000 Disposed 37497 Direct
2020-01-06 Common Stock S 86 $48.168 Disposed 5228 Indirect

Footnotes

F1: Represents a charitable donation by the Reporting Person.

F2: Includes 276 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2019.

F3: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 270 RSUs from a January 3, 2018 grant of 1,079 RSUs.